Vitamin D and Vitamin D Receptor Polymorphism in Asian Adolescents with Primary Dysmenorrhea

Overview

Journal BMC Womens Health

Publisher Biomed Central

Specialty Gynecology & Obstetrics

Date 2023 Aug 5

PMID 37543584

Authors

Ainur Donayeva

Ainur Amanzholkyzy

Roza Nurgaliyeva

Gulnara Gubasheva

Samat Saparbayev

Dinmukhamed Ayaganov

Aiman Kaldybayeva

Ibrahim A Abdelazim

Mohamed M Farghali

Affiliations

Soon will be listed here.

Abstract

Background: The expression of vitamin D receptor in the normal endometrium and ovaries supports the role of vitamin D in local immunity and inflammatory cytokines regulation.

Objective: This study aimed to detect the relation between serum 25(OH)D and primary dysmenorrhea in Asian Adolescents.

Methods: Two hundred and five (205) adolescents complaining of primary dysmenorrhea (study group) were compared in this prospective study to matched controls (210 controls) after informed consent following the Helsinki Declaration. After thorough evaluation, including a thorough history and pelvic ultrasound examination, blood samples were collected from the studied adolescents to measure serum 25(OH)D and for vitamin D receptor TaqI (rs731236) genotyping. The studied adolescents' data were analyzed using the Pearson's correlation to detect the relation between serum 25(OH)D and primary dysmenorrhea (primary outcome). The secondary outcome measures the odds of primary dysmenorrhea in Asian adolescents with vitamin D receptor TaqI (rs731236) polymorphism.

Results: The serum 25(OH)D was significantly lower in the studied-dysmenorrhea group compared to controls (16.17 ± 7.36 versus 17.65 ± 6.36 ng/ml, respectively), (P = 0.01). The correlation analysis showed a significant negative correlation between the serum 25(OH)D and visual analogue scale of dysmenorrhea (r = -0.9003, P < 0.0001). The studied-dysmenorrhea cases with vitamin D receptor T/t and t/t genotypes had significantly lower serum 25(OH)D (16.7 ± 8.05 and 14.4 ± 4.1 ng/ml, respectively) compared to controls (18.97 ± 6.7 and 21.4 ± 2.45 ng/ml, respectively), (P = 0.02 and 0.004, respectively). The VDR T/t and t/t polymorphisms significantly increase the odds of primary dysmenorrhea (OR 1367.2, P < 0.0001 and OR 106.2, P = 0.001, respectively).

Conclusion: The serum 25(OH)D was significantly lower in the studied-dysmenorrhea group compared to controls. The studied-dysmenorrhea cases with VDR T/t and t/t TaqI genotypes had significantly lower serum 25(OH)D compared to controls. The VDR T/t and t/t polymorphisms significantly increase the odds of primary dysmenorrhea.

Citing Articles

The effect of vitamin D on adolescents' primary dysmenorrhea.

Donayeva A, Amanzholkyzy A, Abdelazim I, Kurmangazin M, Khamidullina Z, Kurmanalina M J Med Life. 2024; 16(11):1658-1662.

PMID: 38406787 PMC: 10893579. DOI: 10.25122/jml-2023-0290.

The effects of vitamin D and calcium on primary dysmenorrhea: a systematic review.

Donayeva A, Amanzholkyzy A, Abdelazim I, Saparbayev S, Nurgaliyeva R, Kaldybayeva A J Med Life. 2024; 16(11):1597-1605.

PMID: 38406773 PMC: 10893561. DOI: 10.25122/jml-2023-0248.

The impact of primary dysmenorrhea on adolescents' activities and school attendance.

Donayeva A, Amanzholkyzy A, Abdelazim I, Nurgaliyeva R, Gubasheva G, Saparbayev S J Med Life. 2024; 16(10):1462-1467.

PMID: 38313177 PMC: 10835561. DOI: 10.25122/jml-2023-0247.

Assessing psychometric challenges and fatigue during the COVID-19 pandemic.

Mamyrbaev A, Turmukhambetova A, Bermagambetova S, Satybaldieva U, Erimbetova G, Shayakhmetova K J Med Life. 2024; 16(10):1527-1533.

PMID: 38313168 PMC: 10835555. DOI: 10.25122/jml-2023-0244.

References

Mohseni H, Amani R, Hosseini S, Ekrami A, Ahmadzadeh A, Latifi S . Genetic Variations in VDR could Modulate the Efficacy of Vitamin D3 Supplementation on Inflammatory Markers and Total Antioxidant Capacity among Breast Cancer Women: A Randomized Double Blind Controlled Trial. Asian Pac J Cancer Prev. 2019; 20(7):2065-2072. PMC: 6745231. DOI: 10.31557/APJCP.2019.20.7.2065. View

Abdi F, Ozgoli G, Rahnemaie F . A systematic review of the role of vitamin D and calcium in premenstrual syndrome. Obstet Gynecol Sci. 2019; 62(2):73-86. PMC: 6422848. DOI: 10.5468/ogs.2019.62.2.73. View

Iacovides S, Avidon I, Baker F . What we know about primary dysmenorrhea today: a critical review. Hum Reprod Update. 2015; 21(6):762-78. DOI: 10.1093/humupd/dmv039. View

. ACOG Committee Opinion No. 760: Dysmenorrhea and Endometriosis in the Adolescent. Obstet Gynecol. 2018; 132(6):e249-e258. DOI: 10.1097/AOG.0000000000002978. View

Kucukceran H, Ozdemir O, Kiral S, Berker D, Kahveci R, Ozkara A . The impact of circulating 25-hydroxyvitamin and oral cholecalciferol treatment on menstrual pain in dysmenorrheic patients. Gynecol Endocrinol. 2018; 35(1):53-57. DOI: 10.1080/09513590.2018.1490407. View

Ju H, Jones M, Mishra G . The prevalence and risk factors of dysmenorrhea. Epidemiol Rev. 2013; 36:104-13. DOI: 10.1093/epirev/mxt009. View

Adilgereyeva A, Abdelazim I, Zhurabekova G, El-Ghazaly T . Morphological parameters of ovarian masses and accuracy of the risk of malignancy index in diagnosing ovarian malignancy. Prz Menopauzalny. 2022; 21(2):81-91. PMC: 9528815. DOI: 10.5114/pm.2022.116402. View

Amzajerdi A, Keshavarz M, Ghorbali E, Pezaro S, Sarvi F . The effect of vitamin D on the severity of dysmenorrhea and menstrual blood loss: a randomized clinical trial. BMC Womens Health. 2023; 23(1):138. PMC: 10045437. DOI: 10.1186/s12905-023-02284-5. View

Bashmakova N, Lisovskaya T, Vlasova V . Pathogenetic role of vitamin D deficiency in the development of menstrual dysfunction in pubertal girls: a literature review. Gynecol Endocrinol. 2017; 33(sup1):52-55. DOI: 10.1080/09513590.2017.1404235. View

10.

De Sanctis V, Soliman A, Elsedfy H, Soliman N, Soliman R, El Kholy M . Dysmenorrhea in adolescents and young adults: a review in different country. Acta Biomed. 2017; 87(3):233-246. PMC: 10521891. View

11.

Karacin O, Mutlu I, Kose M, Celik F, Kanat-Pektas M, Yilmazer M . Serum vitamin D concentrations in young Turkish women with primary dysmenorrhea: A randomized controlled study. Taiwan J Obstet Gynecol. 2018; 57(1):58-63. DOI: 10.1016/j.tjog.2017.12.009. View

12.

Jiang W, Hua X, Hu C, Li F, Huang K, Zhang X . The prevalence and risk factors of menstrual pain of married women in Anhui Province, China. Eur J Obstet Gynecol Reprod Biol. 2018; 229:190-194. DOI: 10.1016/j.ejogrb.2018.09.002. View

13.

Rosales-Alexander J, Balsalobre Aznar J, Magro-Checa C . Calcium pyrophosphate crystal deposition disease: diagnosis and treatment. Open Access Rheumatol. 2014; 6:39-47. PMC: 5045115. DOI: 10.2147/OARRR.S39039. View

14.

Bahrami A, Avan A, Sadeghnia H, Esmaeili H, Tayefi M, Ghasemi F . High dose vitamin D supplementation can improve menstrual problems, dysmenorrhea, and premenstrual syndrome in adolescents. Gynecol Endocrinol. 2018; 34(8):659-663. DOI: 10.1080/09513590.2017.1423466. View

15.

Kulsoom U, Khan A, Saghir T, Nawab S, Tabassum A, Fatima S . Vitamin D receptor gene polymorphism TaqI (rs731236) and its association with the susceptibility to coronary artery disease among Pakistani population. J Gene Med. 2021; 23(12):e3386. DOI: 10.1002/jgm.3386. View

16.

El-Ghazaly T, Abdelazim I, Elshabrawy A . Intrauterine Levobupivacaine Instillation for Pain Control in Women Undergoing Diagnostic Hysteroscopy. Gynecol Minim Invasive Ther. 2023; 11(4):209-214. PMC: 9844048. DOI: 10.4103/gmit.gmit_48_21. View

17.

Thota C, Laknaur A, Farmer T, Ladson G, Al-Hendy A, Ismail N . Vitamin D regulates contractile profile in human uterine myometrial cells via NF-κB pathway. Am J Obstet Gynecol. 2013; 210(4):347.e1-347.e10. PMC: 3972355. DOI: 10.1016/j.ajog.2013.11.027. View

18.

Abdi F, Amjadi M, Zaheri F, Rahnemaei F . Role of vitamin D and calcium in the relief of primary dysmenorrhea: a systematic review. Obstet Gynecol Sci. 2021; 64(1):13-26. PMC: 7834752. DOI: 10.5468/ogs.20205. View

19.

Holick M, Binkley N, Bischoff-Ferrari H, Gordon C, Hanley D, Heaney R . Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011; 96(7):1911-30. DOI: 10.1210/jc.2011-0385. View

20.

Lasco A, Catalano A, Benvenga S . Improvement of primary dysmenorrhea caused by a single oral dose of vitamin D: results of a randomized, double-blind, placebo-controlled study. Arch Intern Med. 2012; 172(4):366-7. DOI: 10.1001/archinternmed.2011.715. View